Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13501 | 768 | 37.2 | 69% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHIRURG D | Address | 3 | 100% | 0% | 3 |
2 | ALCOHOLIC LIVER DISEASE ALD | Author keyword | 1 | 31% | 1% | 4 |
3 | CHRONIC HEPATITIS INDUCED BY ALCOHOL | Author keyword | 1 | 100% | 0% | 2 |
4 | DIGEST DIS SECT 111D | Address | 1 | 30% | 0% | 3 |
5 | CHAIR MED STAT EPIDEMIOL | Address | 1 | 33% | 0% | 2 |
6 | ACTIVE CIRRHOSIS | Author keyword | 1 | 50% | 0% | 1 |
7 | ALCOHOL DIS | Address | 1 | 50% | 0% | 1 |
8 | ALCOOL ADDICT | Address | 1 | 50% | 0% | 1 |
9 | ANTIBODY TO HCV | Author keyword | 1 | 50% | 0% | 1 |
10 | ASPARATATE AMINOTRANSFERASE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AFLATOXIN B 1 EXPOSURE | 2 | 67% | 0% | 2 |
2 | HBV DNA HYBRIDIZATION | 2 | 50% | 0% | 3 |
3 | SYMPTOMATIC LIVER CIRRHOSIS | 2 | 50% | 0% | 3 |
4 | HEPATOCELLULAR CARCINOMA RISK | 2 | 26% | 1% | 5 |
5 | NON ASIANS | 1 | 50% | 0% | 2 |
6 | FUKUOKA | 1 | 29% | 1% | 4 |
7 | VIRUS ANTIBODIES | 1 | 10% | 1% | 9 |
8 | ANTI HCV ANTIBODIES | 1 | 17% | 1% | 5 |
9 | REPLICON EXPRESSION | 1 | 25% | 0% | 3 |
10 | C VIRAL INFECTIONS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Risk Factors of Hepatocellular Carcinoma - Current Status and Perspectives | 2012 | 34 | 103 | 38% |
Mechanisms of synergy between alcohol and hepatitis C virus | 2007 | 38 | 112 | 69% |
Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection | 2009 | 74 | 32 | 34% |
Prevalence of Hepatitis C Virus Infection in Alcoholic Patients: Cohort Study and Systematic Review | 2013 | 3 | 29 | 83% |
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer | 2009 | 36 | 84 | 52% |
Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures | 2011 | 73 | 68 | 24% |
Hepatocellular Carcinoma - Epidemiological Trends and Risk Factors | 2009 | 206 | 128 | 12% |
Environmental factors as disease accelerators during chronic hepatitis C | 2008 | 40 | 77 | 40% |
Hepatitis C and alcohol - Interactions, outcomes, and implications | 2003 | 70 | 104 | 44% |
Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence | 2006 | 69 | 150 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHIRURG D | 3 | 100% | 0.4% | 3 |
2 | DIGEST DIS SECT 111D | 1 | 30% | 0.4% | 3 |
3 | CHAIR MED STAT EPIDEMIOL | 1 | 33% | 0.3% | 2 |
4 | ALCOHOL DIS | 1 | 50% | 0.1% | 1 |
5 | ALCOOL ADDICT | 1 | 50% | 0.1% | 1 |
6 | BRANCH CANC RISK PRAISAL PREVENT | 1 | 50% | 0.1% | 1 |
7 | CANC ETIOL INTERVENT LIAONING PROV | 1 | 50% | 0.1% | 1 |
8 | EQUIPE AVENIR VIRUS HEPATITE C | 1 | 50% | 0.1% | 1 |
9 | GENET EPIDEMIOL CLIN SCI | 1 | 50% | 0.1% | 1 |
10 | HLTH HUMAN SERVNUTR EPIDEMIOL BRANCH | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000173090 | ANGIOTONIN//HOSP UNIV CASSIANO ANTONIO DE MORAIS//HYPERTENSIN |
2 | 0.0000112624 | INJECTING DRUG USE//HEPATITIS C TREATMENT//VIRAL HEPATITIS CLIN PROGRAM |
3 | 0.0000110359 | ASIAN CANCER CONTROL//BUR HLTH TECHNOL RD PLANNING BUDGET MANAGEMENT//EARLY DETECT PREVENT |
4 | 0.0000108332 | ALCOHOLIC LIVER DISEASE//ALCOHOLIC HEPATITIS//HEPATOBIOL TOXICOL |
5 | 0.0000106941 | RIBA//ANTI HCV//NON A NON B HEPATITIS |
6 | 0.0000106416 | AMPHIREGULIN AREG//IDOXIFENE//DIGEST CARDIOVASC MED |
7 | 0.0000093876 | STEATOSIS//HEPATOGENOUS DIABETES//DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI |
8 | 0.0000091936 | PRIMATE INFECT DIS//SYNTHETIC COPOLYMER ANTIGENS//EMORY ALCOHOL LUNG BIOL |
9 | 0.0000076558 | HEPATOCELLULAR CARCINOMA//TRANSARTERIAL CHEMOEMBOLIZATION//MIRIPLATIN |
10 | 0.0000073274 | RATE OF DEATH//PROGRAM HEPATOL//HEPATOLOGIST |